If you need new insight on substance dependency treatments, NAD IV therapy in Toronto may appeal to you.
From alcohol overconsumption to other forms of substance abuse, compulsive substance use has many faces; and everyone responds differently when they’re recuperating. Relapses can occur. Mental health can decline. Health concerns that were never an issue may creep up, like anxiety, depression, diabetes, liver disease, cardiovascular health and oxidative stress.
Overusing harmful substances can trigger negative effects on the person who’s using the substance, as well as their surrounding loved ones and socioeconomic status. In fact, compulsive substance abuse is considered by many health care practitioners to be “endemic” in select populations.
Due to the impact addiction has on brain health and body stress, functional medicine health care providers agree that well-rounded treatments – which focus on healing the mind, body, and spirit – could promote recovery from substance abuse.
At the Toronto Functional Medicine Centre (TFMC) NAD IV therapy is used as adjunct support for compulsion syndrome recovery needs. Read on to learn about intravenous treatments, NAD IV therapy as adjunct support, and how to reach us.
IV Therapy and NAD: What Are They?
Known as intravenous infusion therapy, IV therapy is one of the functional medicine treatments available at the TFMC that’s used for resolving nutritional deficiencies and helping to reach optimal health.
IV therapy promotes nutrient absorption by inserting an IV solution into the veins and blood flow. It’s suitable for patients who suffer from dysphagia or malabsorption, without instigating side effects that commonly result from ingesting oral supplements. It can be modified into NAD IV therapy, which can help with cellular functions, mood support, and immune function.
NAD stands for nicotinamide adenine dinucleotide, and it’s an essential coenzyme the human body thrives on for optimal functioning. NAD is accountable for numerous functions, including: cellular energy production and cell health replenishment; preventing mitochondrial dysfunction; and activating chemical reactions for cellular energy metabolism. “Evidence from animal studies indicates that interventions that increase NAD levels produce numerous benefits on the overall cardiometabolic health and immune function,” states a Pharmaceuticals article.
Since NAD influences cellular functioning, recent studies have shown that NAD IV therapy could have beneficial effects on substance abuse recovery.
NAD IV Therapy for Dealing with Substance Dependency
NAD IV therapy could help lessen withdrawal effects when it’s combined with a medical detox program, regular visits with a therapist/counselor, a support group and a functional medicine nutritional program.
Recent studies have established that, because metabolism and enzymes rely on NAD, NAD may affect the “signaling processes” related to compulsive substance use. “These studies implicate raising intracellular NAD+ levels as a potential target for managing and treating [compulsive] behavior and reducing cravings and withdrawal symptoms in patients with food [compulsion] and/or substance abuse,” confirms Antioxidants.
In particular, studies have shown that depression and anxiety tend to be linked to mitochondrial dysfunction. So it’s plausible that NAD IV therapy could be considered as mood support for recovering from substance overindulgence, especially since NAD already supports cellular and DNA repair.
Substance compulsion recovery involves several aspects of health, such as cell health replenishment, cardiovascular health, mental health and adverse brain chemical changes. Please call us if you’re interested in combining NAD IV therapy with your detox program, counseling, support group, and functional medicine program.
How to Contact Us for NAD Intravenous Treatments in Toronto
At our Yorkville clinic, freshly compounded intravenous drips are designed to tackle DNA repair, oxidative stress, and brain fog. Our roster of intravenous therapies includes NAD IV therapy, as well as high-dose vitamin C (ascorbic acid) for immune function, amino acids for energy improvement, and anti-aging IV therapy. Plus, we can personalize your IV therapy treatment! Intravenous drips can be customized to target athletic performance, cognitive performance, energy levels, and more.
Our private integrative functional medicine practice emphasizes naturopathy, allopathic medicine, acupuncture, and other modalities. Next to brain health, we can also assist with chronic health diseases, chronic infections, rheumatoid arthritis, blood sugar management, and other health concerns.
Disclaimer: The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.
Braidy N, Villalva MD, van Eeden S. Sobriety and Satiety: Is NAD+ the Answer?. Antioxidants (Basel). 2020;9(5):425. Published 2020 May 14. doi:10.3390/antiox9050425
Blum K, Oscar-Berman M, Stuller E, et al. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. 2012;3(5):139-. doi:10.4172/2155-6105.1000139.
Blum, Kenneth; Braverman, Eric R; Holder, Jay M; Lubar, Joel F; Monastra, Vincent J; Miller, David & Comings, David E (November 2000). Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive, and Compulsive Behaviors. Journal of Psychoactive Drugs 32 (Supplement): i–iv, 1–112.
Blum K, Downs BW, Dushaj K, et al. THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS. Precision medicine. 2016;1(1):18-33.
Blum, Kenneth; Noble, Ernest; Peter J. Sheridan; Anne Montgomery; Terry Ritchie; Pudur Jagadeeswaran; Harou Nogami; Arthur H. Briggs; Jay B. Cohn (April 18, 1990). Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism. Journal of the American Medical Association 263 (15): 2055–60.
Brown, M.T.C., et al. Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation. PLoS One. 5:12: e15870, 2010.
Cleary, JP. A Consideration of Niacin as an Inhibitor of the Predatory Response. Journal of Orthomolecular Medicine Vol. 18, No. 1, 2003.
Dimitrijević I., Popović N., Sabljak V., Škodrić-Trifunović V., Dimitrijević N. Food addiction-diagnosis and treatment. Psychiatr. Danub. 2015;27:101–106.
Miller M, Chen AL, Stokes SD, et al. Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)TM Improves Behavioral Outcomes in a Residential Treatment Program: A Pilot Study. Journal of psychoactive drugs. 2012;44(5):398-409.
NAD+ metabolism in health and disease. Peter Belenky, Katrina L. Bogan, Charles Brenner. Trends Biochem Sci. 2007 Jan; 32(1): 12–19. Published online 2006 Dec 11. doi: 10.1016/j.tibs.2006.11.006
National Institute on Drug Abuse (http://www.drugabuse.gov). Updated March 2017.
S. Owen, M.D., P. Norris, M.Ed., LPC, DAPA, S. Broom Gibson, Ph.D., R. Mestayer, M.D. Neurotransmitter Restoration Therapy for the Treatment of Substance Abuse. Presentation at Society for Neuroscience annual meeting, Nov. 2008.
Radenkovic D, Reason, Verdin E. Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals (Basel). 2020;13(9):247. Published 2020 Sep 15. doi:10.3390/ph13090247
Riegel, A.C., and Kalivas, P.W. Neuroscience: Lack of inhibition leads to abuse. Nature 463: 743–744, 2010.
Shirayama Y, Chaki S. Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents. Current Neuropharmacology. 2006;4(4):277-291.
The NAD Deficiency Diseases. John P. Cleary, M.D.1. Journal of Orthomolecular Medicine Vol. 1, No. 3. 2937 Monroe Street Madison, WI 53711.
Valenzuela, C.F. Alcohol and Neurotransmitter Interactions. Alcohol Health & Research World Vol. 21, No. 2, 1997.